According to the fixed‑dose combination (FDC) guidelines in India, what is the appropriate anti‑tuberculosis regimen for a child weighing 24 kg?

ATT FDC Dosing for 24 kg Child in India

For a 24 kg child in India, the appropriate fixed-dose combination (FDC) regimen is 3 tablets of the WHO-recommended pediatric FDC formulation (containing rifampicin 75 mg, isoniazid 50 mg, and pyrazinamide 150 mg per tablet) daily for the intensive phase, followed by 3 tablets of the continuation phase FDC (rifampicin 75 mg and isoniazid 50 mg) daily.

Weight Band Classification

A 24 kg child falls into the 20-30 kg weight band according to Indian RNTCP guidelines 1. This weight band requires careful attention as it represents a transition zone where dosing must be optimized to prevent undertreatment.

Intensive Phase (First 2 Months)

For the 20-30 kg weight band, the child should receive:

• Rifampicin: 225 mg daily (3 tablets × 75 mg = 225 mg, achieving ~9.4 mg/kg)
• Isoniazid: 150 mg daily (3 tablets × 50 mg = 150 mg, achieving ~6.3 mg/kg)
• Pyrazinamide: 450 mg daily (3 tablets × 150 mg = 450 mg, achieving ~18.8 mg/kg)
• Ethambutol: If indicated, 400 mg daily (~16.7 mg/kg) 2

Continuation Phase (Next 4 Months)

• Rifampicin: 225 mg daily (3 tablets × 75 mg)
• Isoniazid: 150 mg daily (3 tablets × 50 mg)

Critical Dosing Considerations

Rifampicin Exposure is Key

Rifampicin exposure is the single most important predictor of treatment outcome 3. Children in the 20-30 kg range receiving standard FDC dosing may achieve suboptimal rifampicin concentrations, particularly if HIV-coinfected or malnourished. The target rifampicin dose should be 10-20 mg/kg daily 4, 5.

Common Pitfalls to Avoid

1. Underdosing Risk: The RNTCP patient-wise boxes have been criticized for delivering inadequate doses at certain weights within each band 6. A 24 kg child is at the upper end of the 20-30 kg band and may require monitoring for adequate response.

2. Static Dosing Problem: If the child gains weight during treatment and crosses into the next weight band (>30 kg), the dose must be adjusted immediately 6. Failure to do so results in progressive underdosing.

3. HIV Coinfection: HIV-positive children require up to 190% higher rifampicin doses to achieve adequate exposure 3. Consider individual drug dosing rather than FDC if HIV-coinfected.

4. Malnutrition: Malnourished children may have altered pharmacokinetics and are at higher risk of hepatotoxicity when isoniazid exceeds 10 mg/kg 7. Add pyridoxine 25-50 mg daily 5.

Monitoring and Adjustments

• Weight monitoring: Check weight monthly; adjust dosing if child crosses weight band thresholds
• Treatment adherence: Daily directly observed therapy (DOT) is strongly recommended 1, 8
• Clinical response: Assess at 2 months; if poor response or HIV-positive, consider therapeutic drug monitoring
• Hepatotoxicity surveillance: Monitor for clinical signs (fever, malaise, vomiting, jaundice) especially in first 2 months 7

Alternative Considerations

If the child is HIV-positive, severely malnourished, or shows poor clinical response, consider using individual drug formulations to achieve higher rifampicin dosing (15-20 mg/kg) rather than FDC tablets 4, 3. The newer 4-month regimen (2HRZ(E)/2HR) is now recommended for children with nonsevere TB, but requires specific formulations not yet universally available in India 9.

The daily FDC regimen has demonstrated superior outcomes compared to intermittent regimens in Indian settings 8, making adherence to daily dosing critical for treatment success.